0.023821
0.000000
0.000000
0.000000
0.023821
0.000000
0.000000
0.000000
0.011246
0.00000
0.00000
0.00000
Gamble, T.R.
Yoo, S.
Vajdos, F.F.
Von Schwedler, U.K.
Worthylake, D.K.
Wang, H.
Mccutcheon, J.P.
Sundquist, W.I.
Hill, C.P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
41.980
41.980
88.920
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 Se
196.106
n
SELENOMETHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Science
SCIEAS
0038
0036-8075
278
849
853
10.1126/science.278.5339.849
9346481
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.
1997
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
COLLIMATOR
IMAGE PLATE
1996-12
MARRESEARCH
SI(111)
M
x-ray
1
1.24
1.0
BL1-5
SSRL
1.24
SYNCHROTRON
SSRL BEAMLINE BL1-5
8175.718
HIV CAPSID
C-TERMINAL DOMAIN, RESIDUES 151 - 231
SELENOMETHIONINE SUBSTITUTIONS, L151MSE, M185MSE, M214MSE, M215MSE
1
man
polymer
18.015
water
88
nat
water
no
yes
(MSE)DIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNW(MSE)TETLLVQNANPDCKTILKALGPGATLEE(MSE)
(MSE)TACQG
MDIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNWMTETLLVQNANPDCKTILKALGPGATLEEMMTACQG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Lentivirus
Escherichia
Escherichia coli
sample
BL21
11676
Human immunodeficiency virus 1
469008
Escherichia coli BL21(DE3)
BL21 (DE3)
PET11A
WISP97-7
1
2.21
43.8
VAPOR DIFFUSION, SITTING DROP
8.0
CRYSTALS OF CA(151-231) WERE GROWN AT 4C IN 4 MICROLITER SITTING DROPS CONTAINING A 1:1 MIXTURE OF PROTEIN SOLUTION (2.1 MM CA(151-231) IN 10MM TRIS (PH 8.0) AND 2 MM 2-MERCAPTOETHANOL) AND RESERVOIR SOLUTION (2.0 M AMMONIUM SULFATE), vapor diffusion - sitting drop, temperature 277K
277
repository
Initial release
Version format compliance
Version format compliance
1
0
1998-10-14
1
1
2008-03-24
1
2
2011-07-13
1998-10-14
SPRSDE
Y
BNL
1998-03-27
REL
REL
HOH
water
HOH
1000
2
HOH
HOH
1000
A
HOH
1001
2
HOH
HOH
1001
A
HOH
1002
2
HOH
HOH
1002
A
HOH
1003
2
HOH
HOH
1003
A
HOH
1004
2
HOH
HOH
1004
A
HOH
1005
2
HOH
HOH
1005
A
HOH
1006
2
HOH
HOH
1006
A
HOH
1007
2
HOH
HOH
1007
A
HOH
1008
2
HOH
HOH
1008
A
HOH
1009
2
HOH
HOH
1009
A
HOH
1010
2
HOH
HOH
1010
A
HOH
1011
2
HOH
HOH
1011
A
HOH
1012
2
HOH
HOH
1012
A
HOH
1013
2
HOH
HOH
1013
A
HOH
1014
2
HOH
HOH
1014
A
HOH
1015
2
HOH
HOH
1015
A
HOH
1016
2
HOH
HOH
1016
A
HOH
1017
2
HOH
HOH
1017
A
HOH
1018
2
HOH
HOH
1018
A
HOH
1019
2
HOH
HOH
1019
A
HOH
1020
2
HOH
HOH
1020
A
HOH
1021
2
HOH
HOH
1021
A
HOH
1022
2
HOH
HOH
1022
A
HOH
1023
2
HOH
HOH
1023
A
HOH
1024
2
HOH
HOH
1024
A
HOH
1025
2
HOH
HOH
1025
A
HOH
1026
2
HOH
HOH
1026
A
HOH
1027
2
HOH
HOH
1027
A
HOH
1028
2
HOH
HOH
1028
A
HOH
1029
2
HOH
HOH
1029
A
HOH
1030
2
HOH
HOH
1030
A
HOH
1031
2
HOH
HOH
1031
A
HOH
1032
2
HOH
HOH
1032
A
HOH
1033
2
HOH
HOH
1033
A
HOH
1034
2
HOH
HOH
1034
A
HOH
1035
2
HOH
HOH
1035
A
HOH
1036
2
HOH
HOH
1036
A
HOH
1037
2
HOH
HOH
1037
A
HOH
1038
2
HOH
HOH
1038
A
HOH
1039
2
HOH
HOH
1039
A
HOH
1040
2
HOH
HOH
1040
A
HOH
1041
2
HOH
HOH
1041
A
HOH
1042
2
HOH
HOH
1042
A
HOH
1043
2
HOH
HOH
1043
A
HOH
1044
2
HOH
HOH
1044
A
HOH
1045
2
HOH
HOH
1045
A
HOH
1046
2
HOH
HOH
1046
A
HOH
1047
2
HOH
HOH
1047
A
HOH
1048
2
HOH
HOH
1048
A
HOH
1049
2
HOH
HOH
1049
A
HOH
1050
2
HOH
HOH
1050
A
HOH
1051
2
HOH
HOH
1051
A
HOH
1052
2
HOH
HOH
1052
A
HOH
1053
2
HOH
HOH
1053
A
HOH
1054
2
HOH
HOH
1054
A
HOH
1055
2
HOH
HOH
1055
A
HOH
1056
2
HOH
HOH
1056
A
HOH
1057
2
HOH
HOH
1057
A
HOH
1058
2
HOH
HOH
1058
A
HOH
1059
2
HOH
HOH
1059
A
HOH
1060
2
HOH
HOH
1060
A
HOH
1061
2
HOH
HOH
1061
A
HOH
1062
2
HOH
HOH
1062
A
HOH
1063
2
HOH
HOH
1063
A
HOH
1064
2
HOH
HOH
1064
A
HOH
1065
2
HOH
HOH
1065
A
HOH
1066
2
HOH
HOH
1066
A
HOH
1067
2
HOH
HOH
1067
A
HOH
1068
2
HOH
HOH
1068
A
HOH
1069
2
HOH
HOH
1069
A
HOH
1070
2
HOH
HOH
1070
A
HOH
1071
2
HOH
HOH
1071
A
HOH
1072
2
HOH
HOH
1072
A
HOH
1073
2
HOH
HOH
1073
A
HOH
1074
2
HOH
HOH
1074
A
HOH
1075
2
HOH
HOH
1075
A
HOH
1076
2
HOH
HOH
1076
A
HOH
1077
2
HOH
HOH
1077
A
HOH
1078
2
HOH
HOH
1078
A
HOH
1079
2
HOH
HOH
1079
A
HOH
1080
2
HOH
HOH
1080
A
HOH
1081
2
HOH
HOH
1081
A
HOH
1082
2
HOH
HOH
1082
A
HOH
1083
2
HOH
HOH
1083
A
HOH
1084
2
HOH
HOH
1084
A
HOH
1085
2
HOH
HOH
1085
A
HOH
1086
2
HOH
HOH
1086
A
HOH
1087
2
HOH
HOH
1087
A
MSE
151
n
1
MSE
151
A
ASP
152
n
2
ASP
152
A
ILE
153
n
3
ILE
153
A
ARG
154
n
4
ARG
154
A
GLN
155
n
5
GLN
155
A
GLY
156
n
6
GLY
156
A
PRO
157
n
7
PRO
157
A
LYS
158
n
8
LYS
158
A
GLU
159
n
9
GLU
159
A
PRO
160
n
10
PRO
160
A
PHE
161
n
11
PHE
161
A
ARG
162
n
12
ARG
162
A
ASP
163
n
13
ASP
163
A
TYR
164
n
14
TYR
164
A
VAL
165
n
15
VAL
165
A
ASP
166
n
16
ASP
166
A
ARG
167
n
17
ARG
167
A
PHE
168
n
18
PHE
168
A
TYR
169
n
19
TYR
169
A
LYS
170
n
20
LYS
170
A
THR
171
n
21
THR
171
A
LEU
172
n
22
LEU
172
A
ARG
173
n
23
ARG
173
A
ALA
174
n
24
ALA
174
A
GLU
175
n
25
GLU
175
A
GLN
176
n
26
GLN
176
A
ALA
177
n
27
ALA
177
A
SER
178
n
28
SER
178
A
GLN
179
n
29
GLN
179
A
GLU
180
n
30
GLU
180
A
VAL
181
n
31
VAL
181
A
LYS
182
n
32
LYS
182
A
ASN
183
n
33
ASN
183
A
TRP
184
n
34
TRP
184
A
MSE
185
n
35
MSE
185
A
THR
186
n
36
THR
186
A
GLU
187
n
37
GLU
187
A
THR
188
n
38
THR
188
A
LEU
189
n
39
LEU
189
A
LEU
190
n
40
LEU
190
A
VAL
191
n
41
VAL
191
A
GLN
192
n
42
GLN
192
A
ASN
193
n
43
ASN
193
A
ALA
194
n
44
ALA
194
A
ASN
195
n
45
ASN
195
A
PRO
196
n
46
PRO
196
A
ASP
197
n
47
ASP
197
A
CYS
198
n
48
CYS
198
A
LYS
199
n
49
LYS
199
A
THR
200
n
50
THR
200
A
ILE
201
n
51
ILE
201
A
LEU
202
n
52
LEU
202
A
LYS
203
n
53
LYS
203
A
ALA
204
n
54
ALA
204
A
LEU
205
n
55
LEU
205
A
GLY
206
n
56
GLY
206
A
PRO
207
n
57
PRO
207
A
GLY
208
n
58
GLY
208
A
ALA
209
n
59
ALA
209
A
THR
210
n
60
THR
210
A
LEU
211
n
61
LEU
211
A
GLU
212
n
62
GLU
212
A
GLU
213
n
63
GLU
213
A
MSE
214
n
64
MSE
214
A
MSE
215
n
65
MSE
215
A
THR
216
n
66
THR
216
A
ALA
217
n
67
ALA
217
A
CYS
218
n
68
CYS
218
A
GLN
219
n
69
GLN
219
A
GLY
220
n
70
GLY
220
A
author_defined_assembly
2
dimeric
A
MSE
151
SELENOMETHIONINE
A
MSE
1
MET
A
MSE
185
SELENOMETHIONINE
A
MSE
35
MET
A
MSE
214
SELENOMETHIONINE
A
MSE
64
MET
A
MSE
215
SELENOMETHIONINE
A
MSE
65
MET
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
8_665
-y+1,-x+1,-z+1/2
crystal symmetry operation
41.9800000000
41.9800000000
44.4600000000
1
A
CD
LYS
203
A
CD
LYS
53
0
Y
1
A
CE
LYS
203
A
CE
LYS
53
0
Y
1
A
NZ
LYS
203
A
NZ
LYS
53
0
Y
1
A
THR
188
-100.08
-89.70
PARHCSDX.PRO
TOPHCSDX.PRO
TIP3P.PARAMETER
TIP3P.TOPOLOGY
22.6
1.85
0.00
0.00
1.85
0.00
-3.69
BULK SOLVENT MODEL USED
0.253
0.008
0.215
0.215
1.70
25.00
969
9254
10.5
99.5
RANDOM
10000000.00
0.00100
1
RESTRAINED
THROUGHOUT
-2.0
MULTI-WAVELENGTH ANOMALOUS DISPERSION
0.23
0.21
5.00
0.19
0.19
1.70
25.00
88
644
0
0
556
0.005
1.1
20.4
1.01
1.31
1.50
2.12
2.00
2.41
2.00
3.92
2.50
0.328
0.027
0.276
1.81
153
1320
6
10.4
99.1
21.1
1.7
25.0
1A8O
9307
-2.0
0.036
1
15.0
99.6
1.7
1.73
5.0
0.232
98.6
data reduction
DENZO
data scaling
SCALEPACK
model building
X-PLOR
3.843
refinement
X-PLOR
3.843
phasing
X-PLOR
3.843
HIV CAPSID
HIV CAPSID C-TERMINAL DOMAIN
1
N
N
2
N
N
A
PHE
161
A
PHE
11
HELX_P
A
GLU
175
A
GLU
25
1
1
15
A
GLN
179
A
GLN
29
HELX_P
A
GLU
187
A
GLU
37
1
2
9
A
LEU
189
A
LEU
39
HELX_P
A
GLN
192
A
GLN
42
1
3
4
A
PRO
196
A
PRO
46
HELX_P
A
LEU
205
A
LEU
55
1
4
10
A
LEU
211
A
LEU
61
HELX_P
A
ALA
217
A
ALA
67
1
5
7
disulf
2.037
A
CYS
198
A
SG
CYS
48
1_555
A
CYS
218
A
SG
CYS
68
1_555
covale
1.326
A
MSE
151
A
C
MSE
1
1_555
A
ASP
152
A
N
ASP
2
1_555
covale
1.330
A
MSE
185
A
N
MSE
35
1_555
A
TRP
184
A
C
TRP
34
1_555
covale
1.333
A
MSE
185
A
C
MSE
35
1_555
A
THR
186
A
N
THR
36
1_555
covale
1.334
A
MSE
214
A
N
MSE
64
1_555
A
GLU
213
A
C
GLU
63
1_555
covale
1.332
A
MSE
214
A
C
MSE
64
1_555
A
MSE
215
A
N
MSE
65
1_555
covale
1.330
A
MSE
215
A
C
MSE
65
1_555
A
THR
216
A
N
THR
66
1_555
VIRAL PROTEIN
CAPSID, CORE PROTEIN, HIV, C-TERMINAL DOMAIN, Viral protein
POL_HV1N5
UNP
1
1
P12497
GARASVLSGGELDKWEKIRLRPGGKKQYKLKHIVWASRELERFAVNPGLLETSEGCRQILGQLQPSLQTGSEELRSLYNT
IAVLYCVHQRIDVKDTKEALDKIEEEQNKSKKKAQQAAADTGNNSQVSQNYPIVQNLQGQMVHQAISPRTLNAWVKVVEE
KAFSPEVIPMFSALSEGATPQDLNTMLNTVGGHQAAMQMLKETINEEAAEWDRLHPVHAGPIAPGQMREPRGSDIAGTTS
TLQEQIGWMTHNPPIPVGEIYKRWIILGLNKIVRMYSPTSILDIRQGPKEPFRDYVDRFYKTLRAEQASQEVKNWMTETL
LVQNANPDCKTILKALGPGATLEEMMTACQGVGGPGHKARVLAEAMSQVTNPATIMIQKGNFRNQRKTVKCFNCGKEGHI
AKNCRAPRKKGCWKCGKEGHQMKDCTERQANFLGKIWPSHKGRPGNFLQSRPEPTAPPEESFRFGEETTTPSQKQEPIDK
ELYPLASLRSLFGSDPSSQ
283
351
1A8O
152
220
P12497
A
1
2
70
96
P 43 21 2